In this case-control study, our primary objective was to detect small fiber neuropathy (SFN) among patients who experienced sensory symptoms and pain following the acute phase of COVID-19. Additionally, we sought to investigate potential risk factors associated with the development of SFN and to delve into the mechanisms contributing to the occurrence of post-COVID-19 pain.
No takes yet. Share an insight, caveat, or question.
Falco et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: